Maybe it’s a result of the lack of information on progress. All the delays due to reformulation from AD-114 may be wearing thin with some. The manufacturing process is meant to be completed in May 19, then on to toxicology Studies.
We are 1 year behind where AD-114 was meant to be.
Ann: Major shareholder fund expiry extended, page-4
Add 1AD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.05M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 718710 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 560699 | 4 |
View Market Depth
| Last trade - 16.13pm 15/11/2024 (20 minute delay) ? |
| 1AD (ASX) Chart |
Day chart unavailable